It has been an honor and an adventure helping judge the Biotech Humanitarian Award again this year.
I’m pleased to announce that this year’s honor goes to Dr. Paul Offit, Chief of the Division of Infectious Diseases and the Director of the Vaccine Education Center at The Children’s Hospital of Philadelphia.
Dr. Offit was selected as the 2011 Honoree in recognition of his 25 years spent dedicated to developing RotaTeq, one of the main vaccines currently used to fight rotavirus, a disease that is the leading cause of severe, dehydrating diarrhea in infants and young children. RotaTeq is recommended for universal use in infants by the Center for Disease Control and has the capacity to save as many as 2,000 lives per day.
The third issue of Scientic American’s Worldview is now available at www.saworldview.com.
In this latest issue I continue my comparative assessment of the biotechnology innovation environment in different countries. I also include additional highlights:
- Which country is home to the most drug inventors?
- Which country has the greatest biotechnology patenting intensity?
- Which country has the greatest relative biotechnology R&D spend?
- Which country has the most global collaboration on innovation?
- Which region has the fastest growing drug market?
- Which country has the largest drug market?
- Which country has the longest drug approval lag
- Which country has the most publications in the field of biotechnology?
- Which country is the largest drug exporter?
- Which country has the strongest public biotechnology markets?
I have also increased the number of countries measured from 38 last year to 48 this year.
The answers to these questions may suprise you. For answers to these questions and more, see the Scientific American Worldview project at www.saworldview.com
Michael Salgaller will be signing his book, Biotechnology Entrepreneurship: From Science to Solutions, today at the BIO convention from 9am to 10:30am in the BIO bookstore.
John Avellanet will be signing his book, Get to Market Now! Turn FDA Compliance into a Competitive Edge in the Era of Personalized Medicine, today at the BIO convention from 10:30am to 12:30pm in the BIO bookstore.
Looking for a place to cut a deal, or some sightseeing suggestions while you’re in DC for the BIO convention? I’ve compiled a list in the June issue of the Burrill Report.
I will be giving a brief talk on the Cuban Biotechnology industry during a panel at the Biotechnology Industry Organization conference today.
What: Cuban Biotechnology: An Overview of Cuba’s Drug and Vaccine Developments and Innovations
When: 2:00 – 2:45pm
Where: Room 145B
Who: Elaine Scheye, Yali Friedman, Halla Thortsteinsdottir, Pedro Freyre
I will be largely citing papers published in the Journal of Commercial Biotechnology and providing a brief overview and SWOT analysis of Cuban biotechnology.
Mark Ahn, Michael Alvarez, and Anne York, the editors of Building the Case for Biotechnology: Management Case Studies in Science, Laws, Regulations, Politics, and Business will be signing books today at the BIO 2011 Convention in Washington DC from 3:00-4:30 pm in the BIO bookstore.
The following Logos Press authors will be signing books at the BIO 2011 Convention in Washington DC
Monday June 27th 3:00-4:30pm
Mark Ahn, Michael Alvarez, Anne York
Tuesday June 28th 3pm-4:30pm
- Building Biotechnology: The definitive biotechnology industry primer
- Best Practices in Biotechnology Business Development: Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property
- Best Practices in Biotechnology Education 22 International Best Practices in K-12, College, Certificate, Master’s, Doctoral, MBA, Distance Education Programs and Student Groups
Wednesday June 29th 10:30am-12:30pm